People · Operator
Named in public records as an officer, director or promoter · active 2018–2022 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| FusiForm, Inc. | — | Other Technology | Series A | $8.8M | $71.5M | 2018 |
| Pearl Diagnostics, Inc. | — | Biotechnology | Seed | $3.5M | $62.8M | 2022 |
| Signal Vine, Inc. | — | Other Technology | Seed | $2.7M | $42.6M | 2020 |
John Cammack at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Cammack on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Lee | 1 | 15 |
| Eric Carlborg | 1 | 14 |
| Robb Doub | 1 | 6 |
| Jason Palmer | 1 | 5 |
| Hugh Evans | 1 | 4 |
| Robert Proctor | 1 | 3 |
| Kieren Marr | 1 | 2 |
| Brian Kathman | 1 | 2 |
| Diana Oblinger | 1 | 2 |
| Alex Mathews | 1 | 1 |
| Param Shah | 1 | 1 |
| Dan Najjum | 1 | 1 |
| Ralph Passarella | 1 | 1 |
| Jamie Riepe | 1 | 1 |
| Brad Spellberg | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.